New and Updated Clinical Influenza Vaccine Trials

Latest Influenza vaccine studies updated or received at ClinicalTrials.gov. Only open studies, recruiting or not yet recruiting, are shown found by a search using the keyword: "influenza"

A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age
Sep 29, 2023 | 06:00 am
Conditions: Respiratory Syncytial Virus Interventions: Biological: Placebo; Biological: mRNA-1345; Biological: Fluzone HD Sponsors: ModernaTX, Inc. Not yet recruiting
Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24
Sep 28, 2023 | 06:00 am
Conditions: Influenza Immunization (Healthy Volunteers) Interventions: Biological: Quadrivalent Influenza Vaccine; Biological: High-Dose Quadrivalent Influenza Vaccine Sponsors: Sanofi Not yet recruiting
Behavioral Economics to Improve Flu Vaccination Using EHR Nudges
Sep 28, 2023 | 06:00 am
Conditions: Behavior, Health; Flu; Flu Vaccination Interventions: Behavioral: Pre-visit patient text messaging; Behavioral: Default pended order; Behavioral: Monthly peer comparison feedback; Behavioral: High risk bidirectional pre-visit text messaging Sponsors: University of Pennsylvania; National Institute on Aging (NIA); University of Washington Not yet recruiting
Randomized Controlled Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP
Sep 26, 2023 | 06:00 am
Conditions: Influenza Interventions: Biological: FLUAD Quadrivalent; Biological: FluQuadri Sponsors: Centers for Disease Control and Prevention; Naval Medical Research Unit- 6; Peruvian Clinical Research; Hospital Nacional Cayetano Heredia; Hospital Nacional Arzobispo Loayza Active, not recruiting
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Sep 26, 2023 | 06:00 am
Conditions: Neuroendocrine Tumor (NET); Colorectal Cancer (CRC) Interventions: Biological: CHM-2101 CAR-T cells; Biological: CHM-2101 CAR-T cells Sponsors: Chimeric Therapeutics Not yet recruiting
Pilot Clinical Investigation to Evaluate a Prototype of Sensor Measuring Ventilator-derived Parameters
Sep 26, 2023 | 06:00 am
Conditions: Mechanically Ventilated Patients Interventions: Device: prototype of sensor Sponsors: Archeon Not yet recruiting
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis
Sep 25, 2023 | 06:00 am
Conditions: Allergic Rhinitis Interventions: Drug: azelastine/fluticasone 137/50 mcg nasal spray; Drug: Dymista™ Sponsors: Synmosa Biopharma Corp. Completed
Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning
Sep 25, 2023 | 06:00 am
Conditions: COVID-19; Post-COVID-19 Syndrome; Influenza Interventions: Other: Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning Sponsors: Lizora LLC; Sheng'ai Traditional Chinese Medicine Hospital Enrolling by invitation
A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
Sep 22, 2023 | 06:00 am
Conditions: Seasonal Influenza Interventions: Biological: Quadrivalent influenza vaccine(0.25ml); Biological: Quadrivalent influenza vaccine(0.5ml); Biological: Trivalent influenza vaccine(BV); Biological: Trivalent influenza vaccine(BY) Sponsors: Sinovac Biotech Co., Ltd Not yet recruiting
Studying Respiratory Infections and Colonisation in Children Using Daily Minimally-invasive Nasal Sampling
Sep 22, 2023 | 06:00 am
Conditions: Respiratory Tract; Infection, Upper (Acute); Colonization, Asymptomatic Sponsors: Leiden University Medical Center; Spaarne Gasthuis Recruiting
H7HLAII DNA Influenza Vaccine
Sep 21, 2023 | 06:00 am
Conditions: Influenza A; Pandemic Influenza Interventions: Biological: H7HLAII Sponsors: Oslo University Hospital Recruiting
Effect of Health Education on Promoting Influenza Vaccination Health Literacy
Sep 21, 2023 | 06:00 am
Conditions: Vaccination; Infection; Influenza Interventions: Combination Product: Health education Sponsors: Sun Yat-sen University Recruiting
Agaricus Bisporus and Influenza Vaccination Response
Sep 18, 2023 | 06:00 am
Conditions: Immune Response Interventions: Biological: Influenza vaccine; Dietary Supplement: Agaricus bisporus capsules; Dietary Supplement: Control capsules Sponsors: Maastricht University Medical Center; Scelta Mycofriends B.V.; CNC Grondstoffen B.V. Not yet recruiting

^ Back to Top

Main Menu

Login Form

Related Links

New and Updated Clinical Influenza Vaccine Trials

A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24

Behavioral Economics to Improve Flu Vaccination Using EHR Nudges

Randomized Controlled Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

Pilot Clinical Investigation to Evaluate a Prototype of Sensor Measuring Ventilator-derived Parameters

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis

Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning

A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

Studying Respiratory Infections and Colonisation in Children Using Daily Minimally-invasive Nasal Sampling

H7HLAII DNA Influenza Vaccine

Effect of Health Education on Promoting Influenza Vaccination Health Literacy

Agaricus Bisporus and Influenza Vaccination Response

Influenza Publications

Influenza News